-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Conduit Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2022 to 2023.
- Conduit Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.14M, a 139% decline year-over-year.
- Conduit Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$8.53M, a 56.5% decline year-over-year.
- Conduit Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$5.26M, a 66.5% decline from 2022.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)